CN(CC(=O)Nc1ccc(F)cc1)C(=O)CCc1nc(O)c2c3c(sc2n1)CCCC3
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?